Condition
Non Infectious Uveitis
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
4Total
Early P 1 (1)
P 1 (1)
P 3 (2)
Trial Status
Not Yet Recruiting2
Recruiting1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07427628Phase 1Not Yet RecruitingPrimary
A Proof-of-concept Trial to EvaluAte the efficaCy and Safety Of Cell Therapy TRX103 in Patients With Active, Non-infectious Uveitis
NCT07145008Early Phase 1Recruiting
Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon
NCT06258915Phase 3Not Yet RecruitingPrimary
Treatment FOr Corticosteroid Dependent UveitiS
NCT03711929Phase 3TerminatedPrimary
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Showing all 4 trials